AR and prostate carcinoma: Finally, studying mutation cooperativity reveals how interactions between multiple gene mutations might also contribute to drug resistance, assisting in identifying new resistance mechanisms and addressing the challenges posed by AR mutations in prostate cancer treatment comprehensively.